Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin vs Oxytocin for PPH Prevention in High-Risk Cesarean Section
NCT04089176Phase 1Completed
- Sponsor
- Ministry of Public Health
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH), sponsored by Ministry of Public Health. Primary endpoint: Additional drug use. Started Feb 2019; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT04089176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04089176.